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Abstract
Background The management of the left subclavian artery
when coverage is necessary during thoracic aorta endografting
remains a matter of debate.
Materials and methods A retrospective analysis of a single-
centre experience with thoracic endovascular aorta repair
(TEVAR) was performed. Between April 2004 and October
2012, 125 cases of TEVAR were performed. The analysis
focused on patients who required coverage of the left
subclavian artery (LSA). We analysed mortality and
morbidity with special attention to the rates of cerebro-
vascular accidents (CVAs) and spinal cord ischaemia
(SCI) in the early and midterm.
Results Of the 125 patients, 53 (42 %, group A) required an
intentional coverage of the LSA to obtain an adequate prox-
imal seal for the endograft; the remaining patients constituted
group B. None of the patients in group A had protective LSA
revascularisation prior to TEVAR. The primary technical suc-
cess rate was 79.2 vs. 90.3 % (group A vs. group B, p=0.08),
and the primary clinical success rate was 77.4 vs. 82 % (group
A vs. group B, p=0.53). The 30-day mortality rate was 11.3
vs. 11.1 % (group A vs. group B, p=0.97). The 30-day
morbidity was 7.5 vs. 13.9 % (group A vs. group B, p=0.4).
CVA occurred in 1.9 % of group A patients, compared to
1.4 % of patients from group B (p=0.82). The SCI incidence
rate was 0 vs. 1.4 % (p=0.39). The mean follow-up of group
A was 24.1 months (range 2–64.6 months, SD=19).
Additionally, the 1-year estimated survival was 85.5 %, and
the 3-year estimated survival was 78 %. There were no mid-
term CVAs; one event of SCI occurred in the seventh post-
operative month in group A.
Conclusion Our analysis, although retrospective and based on
one institution experience, shows a realistic population of
TEVAR patients. We prove that TEVAR with coverage of
LSA origin can be accomplished with minimal neurological
morbidity in this patient population. The study shows that
LSA revascularisation is not mandatory before endograft
deployment, especially in emergency settings. We also
prove that although zone 2 TEVAR extends the proxi-
mal landing zone, it does not prevent type IA endoleaks
from appearing. A multicentre randomised control trial
with higher number of patients is necessary for proper,
robust conclusion to be established.
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Introduction
Thoracic endovascular aortic repair (TEVAR) has rapidly
become an accepted treatment option for numerous aortic
pathologies [1–4]. An important requirement for successful
endografting is confirming the health of the aorta in the
landing zone where the graft is deployed. Left subclavian
artery (LSA) coverage is necessary to achieve the proximal
seal in up to 50 % of patients treated with TEVAR [5–9]. The
management of LSA revascularisation in this cohort of pa-
tients remains a matter of debate. A 2009 consensus from the
Society of Vascular Surgery described the quality of the
existing evidence on the performance of subclavian
revascularisation in patients undergoing TEVAR as low (2C)
[10]. A 2011 literature review from the European Association
for Cardio-Thoracic Surgery, which resulted in the formulation
of recommendation of prophylactic LSA revascularisation in
elective patients, was based on numerous and heterogeneous
series with small samples of patients [11]. Studies in support of
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routine preoperative LSA revascularisation show that the cov-
erage of the LSA during TEVAR is associated with an in-
creased risk of stroke, paraplegia and arm ischaemia. Other
studies have shown that coverage of the LSAwithout prophy-
lactic revascularisation is not associated with increased mor-
bidity, supporting those results promoting selective LSA
revascularisation during TEVAR [7, 12–14]. In this study, we
analysed the consequences of intentional LSA coverage during
TEVAR with special attention to the development of neurolog-
ic complications in a real life, non-selected (“all comers”)
population.
Materials and methods
Between April 2004 and October of 2012, 125 TEVAR pro-
cedures were performed in our department. Of those, 42 %
(n=53) required stent-graft (S-G) deployment with intentional
coverage of the origin of the left subclavian artery (Ishimaru
zones 0–2 [15], group A), and this population constituted our
studied group. The remaining patients had no coverage of the
LSA (Ishimaru zones 3 and 4 [15], group B). We retrospec-
tively reviewed a prospectively maintained database, medical
records and imaging studies. Patients’ characteristics are listed
in Table 1. The outcome measures evaluated included the rate
of cerebrovascular accident (CVA), spinal cord ischaemia
(SCI), and mortality and overall morbidity in early, as well
as midterm observations. CVA was defined as any stroke or
transient ischemic event, regardless of the extent of recovery.
SCI was defined as any transient or permanent paralysis or
paresis at any time after TEVAR.
Preoperative planning was performed on Apple MacBook
Pro systems with OsiriX DICOM Viewer version 3.9.4
(Pixmeo Sàrl, Bernex, Switzerland). The decision on the LSA
coverage was based on preoperative contrast enhanced com-
puted tomography (CTA) of the neck and thorax, evaluating the
anatomy of the thoracic aorta, aortic arch and carotid and
vertebral arteries. The anatomy of the circle of Willis was not
routinely assessed. To further evaluate the cerebrovascular
anatomy, doubtful elective patients in this subgroup underwent
preoperative carotid and vertebral artery duplex Doppler ultra-
sonography. Three-dimensional MPR image reconstructions
were performed to obtain centreline measurements of the aortic
lumen. In patients who did not undergo supplemental preoper-
ative imaging, the arch vessel anatomy was evaluated intraop-
eratively before S-G deployment. In elective cases, a proximal
landing zone of ≥15-mm length was required. In emergency
cases, however, a ≥10-mm proximal aortic “neck”was deemed
suitable. In cases with shorter necks, the decision to cover the
LSA was made. To classify the proximal landing zones, the
aortic arch map with zones 0–4 by Ishimaru [15] was applied.
In cases that required zone 0 TEVAR, patients would initially
attain aortic debranching by the implantation of a bifurcated
bypass from the ascending aorta to the brachiocephalic
trunk and LCCA; later, during the same procedure, the
S-G would be deployed in zone 0. Patients requiring
zone 1 deployment underwent right-to-left carotid-
carotid bypass procedures using an 8-mm Dacron graft.
We practice the strategy of conditional prophylactic
revascularisation of the LSA in patients with patent LIMA-
LAD bypass, dominant left vertebral or hypoplastic right verte-
bral artery, patent left arm dialysis fistula or axillo-femoral
bypass graft. Additionally, intraoperative indications for
LSA revascularisation include symptoms of acute left
arm ischaemia.
From 2004 to 2009, our endovascular team consisted of a
vascular surgeon and an interventional radiologist, and the
procedures were performed in an interventional radiology
suite. From 2009 to the present, a team of vascular and cardiac
surgeons has been performing elective cases using a mobile C-
arm (Siemens ARCADIS Avantic), while emergency cases
are performed in an interventional radiology suite using an
Siemens Artis zee C-arm (vascular surgeon and radiologist)
unless aortic debranching is required (in those cases, the
procedures are performed in the surgical theatre with the use
of mobile C-arm).
In total, 63 % of procedures were performed under general
anaesthesia, and 37 % were performed using loco-regional
anaesthesia and sedation. Rapid pacing was used in one pa-
tient during S-G deployment in the critical landing zone.
Mean procedure time was 119 min ranging from 60 to
210 min.
No intraoperative neurological monitoring was conducted.
Post-operative neurological assessments occurred every 2 h in
the first eight post-operative hours and then every 4 h in
uncomplicated cases (by either treating or on-call surgeon or
anaesthesiologist). Our institution practices a policy of selec-
tive spinal drainage; this was reserved for complicated cases
only. In cases of SCI, spinal drainage and augmentation of the
mean arterial pressure would be utilised.
Table 1 Patients’ demographics
Variable Group A (%) Group B (%) p value
n=53 n=72
Age, median ± SD years 61±15.2 72±14.4 0.06
Male gender 44 (83 %) 52 (72.2 %) 0.16
CAD 6 (11.3 %) 13 (18.1 %) 0.30
Prior MI 1 (1.9 %) 8 (11.1 %) 0.10
Diabetes 5 (9.4 %) 9 (12.5 %) 0.59
Renal failure 0 (0 %) 6 (8.3 %) 0.32
Hypertension 39 (73.6 %) 45 (62.5 %) 0.19
Prior AAA open repair 5 (9.4 %) 7 (9.7 %) 0.95
SD standard deviation, CAD coronary artery disease, MI myocardial
infarction, AAA abdominal aortic aneurysm
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The stent grafts used are described in detail in Table 2.
Thoracic stent-graft delivery was approached through
the common femoral artery in 118 patients, through the
common iliac artery in 4 and through abdominal aorta
in 3 patients. In these cases, an 8-mm vascular prosthe-
sis was implanted end to side toward either the right
common iliac artery or abdominal aorta and was then
used as a technical conduit.
Patient follow-up included history, physical examination
and CTA. Patients were typically seen at 1, 3, 6 and 12months
and annually thereafter. In specific conditions, follow-up was
adjusted accordingly. During follow-up, the patients were
specifically assessed for neurologic changes and evidence of
arm ischaemia. CTA was used to assess the durability of the
stent-graft repair.
Categorical variables were analysed using a nonparametric
χ2 test. In instances where the χ2 test was unreliable due to a
small sample size, the Fisher exact method was employed
to test the association. Continuous variables were pre-
sented as medians, and they did not show a Gaussian
distribution. Survival was analysed with the Kaplan-
Meier and life-table analysis methods. All statistical
analyses were performed using Statistica 7.1 software
(StatSoft Inc., Tulsa, OK).
Primary technical success was defined as the successful
introduction and deployment of the device in the absence of
surgical conversion, death in ≤24 h and type I or III endoleaks,
or graft obstruction [16].
Primary clinical success was defined as the successful
deployment of the endovascular device at the intended location
without death as a result of aneurysm-related treatment, type I
or III endoleaks, graft infection, thrombosis, aneurysm expan-
sion, aneurysm rupture or conversion to open repair [16].
Results
Indications
There were 76 elective (25 in group A and 51 in group
B) and 49 emergency (28 in group A and 21 in group
B) procedures. Among these, 110 were primary and 15
were secondary procedures. The indications for treat-
ment are listed in Table 3. No patient who required
zone 2 coverage had absolute indications for LSA
revascularisation, and therefore, no preoperative
revascularisation of the LSA was performed.
Proximal landing zone
There was one (1.9 %) deployment in zone 0. The proximal
landing zone was zone 1 in 3 patients (5.8 %) and zone 2 in 48
patients (92.3 %). In the remaining cases, stent grafts were
landed in zones either 3 or 4.
The primary technical success rate in group A was
79.2 % (n=42). Assisted primary success was obtained
in one patient (1.9 %) who required additional proce-
dure during the same hospital stay, with proximal S-G
deployment, due to a large type IA endoleak. Secondary
success was obtained in two patients (3.8 %). The first
of these was a female patient treated on an emergency
basis for aortic transection due to vehicle trauma. She
required additional subclavian-carotid transposition and
forearm fasciotomy for acute left arm ischaemia, which
developed after emergency TEVAR with LSA coverage
(procedure performed in hypovolemic shock). Another
patient was also treated on emergency basis (complicat-
ed acute type B aortic dissection). In this case, where
zone 2 deployment was intended, post-deployment aor-
tography revealed the coverage of LCCA origin (acci-
dental zone 1 deployment). The patient was taken to the
operating theatre, and RCCA to LCCA bypass was
performed immediately. However, he developed stroke,
and mild hemiplegia was present when the patient woke
up after the procedure and on the day of discharge from
the hospital. One patient had type III endoleak. Thus,
the overall technical success rate in group A was
84.9 % (n=45).
In group A, five patients had type IA endoleaks on
completion angiography. In three cases, the endoleaks
were minor, and decision on conservative treatment was
made; these endoleaks had sealed upon follow-up ob-
servation and were absent on last follow-up CTA obser-
vations, taken on the 10th, 18th and 26th months after
the procedure, respectively. In one case, a minor
endoleak sealed upon follow-up and was absent on the
last CTA control, performed on the 28th month post-
procedure. Further follow-up contact with the patient
was lost for 1.5 years, but then, he was admitted to
our service in an emergency setting with rapidly enlarg-
ing, symptomatic thoracic aortic aneurysm (TAA) due to
S-G migration and recurrence of type IA endoleak. He
was taken to surgery right away, and debranching of the
aortic arch by implantation of bifurcated prosthesis from
Table 2 Stent grafts used




Zenith TX2 (Cook Inc.,
Bloomington, IN)
34 (64.1 %) 45 (62.5 %)
E-vita Thoracic (JOTEC GmBH,
Hechingen, Germany)
11 (20.7 %) 19 (26.4 %)
Valiant (Medtronic, Minneapolis, MN) 4 (0.7 %) 5 (6.9 %)
Relay (Bolton Medical, Sunrise, FL) 4 (0.7 %) 3 (4.2 %)
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ascending aorta to brachiocephalic trunk and LCCA was
performed. During the deployment of the proximal ex-
tension S-G element in zone 0, the aneurysm ruptured
to the left pleural cavity, and patient died intraopera-
tively. The last patient had a persistent IA endoleak on
angio-CT 20 months after the procedure but refused
another surgery. The aneurysm enlargement to 74 mm
was observed, and the patient is still under ambulatory
surveillance. The initial rate of type IA endoleak was
9.4 % (n=5).
The primary technical success rate in group B was 90.3 %
(n=65).
Three type IA endoleaks were observed on comple-
tion angiography in group B. Conservative management
was used in two cases; the first patient refused second-
ary procedure—at 2.5 months, significant aneurysm en-
largement and rupture were observed with subsequent
death of the patient. In the other case, the endoleak was
minor and no aorta-related MAE was observed. The
third patient had secondary procedure with LSA cover-
age after 14 months with good clinical result (no further
endoleaks). The initial rate of type IA endoleaks was
4.2 % (n=3) in group B.
There were also three type IB endoleaks (4.2 %, n=
3). In one case, type IB endoleak was observed in a
patient treated for ruptured TAA, the patient died on
post-operative day 1 in symptoms of hypovolemic
shock. The remaining two patients had secondary pro-
cedures with distal S-G extensions; in both cases, the
treatment was successful, with complete resolution of
type IB endoleaks.
In one case, intraprocedural distal migration of S-G oc-
curred, SMA origin was covered with the S-G and open
extraction of S-G was performed; the patient died on the first
post-operative day.
Details are listed in Table 4.
Number of grafts used
In group A, 26 patients required only one element, while in 13
patients, two stent-graft elements were used to cover the entire
pathology. In 18 cases, the graft length was higher than
200 mm. Median was 205 mm (min 134 mm, max 332 mm,
standard deviation ±55 mm).
In group B, 40 patients were treated with one stent-graft
element; in 23 patients, two elements were used; and in two
cases, 3 S-G elements were necessary to treat the entire aortic
Table 3 Indications for treatment










25 (47.2 %) 28 (52.8 %) 51 (70.8 %) 21 (29.2 %) 0.007
TAA (mean diameter 75 mm,
range 53–110 mm)
18 (34 %) 44 (61.1 %) 0.0027
5 (9.4 %) 6 (3 rTAA) (8.3 %) 0.83
23 (43.4 %) 53 (73.6 %) 0.0006
Complicated type B dissection 16 (30.2 %) 16 (30.2 %) 8 (11.1 %) 8 (11.1 %) 0.008
TAT 7 (13.2 %) 7 (13.2 %) 4 (5.6 %) 4 (5.6 %) 0.24
Pseudoaneurysm 6 (11.3 %) 6 (11.3 %) 5 (6.9 %) 5 (6.9 %) 0.39
Aortic ulcer 1 (1.9 %) 1 (1.9 %) 2 (2.8 %) 2 (2.8 %) 0.78
TAA thoracic aorta aneurysm, TAT thoracic aorta transection
Table 4 Type IA endoleaks




1 Seal, 26th month Death on 27th month, urinary
bladder carcinoma
2 Seal, 28th month Migration, TAA rupture















1 No seal TAA rupture on 3rd month,
death
2 Seal, 48th month Death on 54th month due
to acute pancreatitis
3 Persistant type IA endoleak Patient refuses surgery
S-G stent graft, TAA thoracic aorta aneurysm
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pathology. In 38 cases, the combined length of covered aorta
was longer than 200 mm with a median of 213 mm (min
127 mm, max 353 mm, standard deviation ±73 mm).
Results based on stent-graft types are described in
Table 5.
In other cases, a retrospective review of the patients’ notes
would not allow us to establish the graft length or number of
elements used.
Type II endoleaks
There were no type II endoleaks originating from covered
LSA in group A. There was two type II endoleaks in group B.
Primary clinical success
The 30-day mortality rate was 11.3 % in group A and 11.1 % in
group B. Therefore, the primary clinical success rate was 77.4 %
(n=41) in group A and 82 % (n=59) in group B. A detailed
description of early mortality may be found in Table 6.
The overall 30-day morbidity was 7.5 % (n=4) in group A
and 13.9 % (n=10) in group B. No access site complications
developed in group A, and there were five access related
complications in group B.
The 30-day mortality and morbidity are listed in Table 7.
Early neurologic complications
One stroke arose during the early observation period
(stroke rate of 1.9 %) in group A and one stroke was
observed in group B (1.4 %). No transient or permanent
paraplegia had developed in group A in the 30-day
observation, compared to one incident of paraparesis in
group B (transient–complete resolution was observed on
follow-up visit on the third month). In comparison with
the group with LSA left uncovered, the experimental
group showed no statistical significance in terms of
CVA (1.9 vs. 1.4 %, p=0.82) or SCI incidence rate (0
vs. 1.4 %, p=0.39).
Midterm clinical success
The mean follow-up of group A was 24.1 months
(range 2–64.6 months, SD =19 months). The 1-year
estimated survival was 87.7 % (standard error =0.047)
for group A vs. 81.7 % (standard error =0.055) for
group B (p=0.64); the 3-year estimated survival was
82.3 % (standard error =0.069) in the studied group
and 81.7 % (standard error =0.055) in group B (p=
0.65) (Fig. 1). The rate of late IA endoleaks in the
studied group during the follow-up period was 9.4 %.
Three type IA leaks (at 16, 20 and 43 months, respec-
tively) were detected. One patient required zone 1
TEVAR after RCCA to LCCA bypass, and a follow-up
CTA revealed sealed endoleak. The two other patients
are on waiting lists for proximal extension procedures.
Two secondary type IB leaks (6 and 18 months) were
detected. Both were treated with secondary interventions
with technical success. No type II leaks were found. No
patients required open conversion.
In one patient, late paraplegia occurred (seventh
month). He was treated for TAA with a history of prior
AAA treatment with straight tube open repair. The MRI
of his spine had revealed an ischemic focus on the T6–
T8 level. In the follow-up CTA, a secondary IA
endoleak was found in this patient (before paraplegia
occurred).
Four cases of left arm ischaemia developed, and all were
managed conservatively, with no need for revascularisation
due to mild symptoms.
Four patients developed subclavian steal syndrome in mid-
term, with only one case becoming so profound that it re-
quired LSA to LCCA transposition. The effect of this proce-
dure was good, with a complete resolution of symptoms and
uneventful post-operative course.
Table 5 Results based on stent-graft type










Zenith TX2 (Cook Inc., Bloomington, IN) 5 1 5 2 3 1
E-vita Thoracic (JOTEC GmBH, Hechingen, Germany) 2 3 1 1
Relay (Bolton Medical, Sunrise, FL) 1 2
Valiant (Medtronic, Minneapolis, MN) 1
Combined 6 5 1 8 3 3 1 1
CVA cerebrovascular accident, SSS subclavian steal syndrome, SCI spinal cord ischaemia
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Discussion
In up to 50 % of cases of TEVAR, coverage of the LSA is
necessary to obtain a seal and to prevent either type IA
endoleaks or stent-graft migration [5–9]. In our population,
the extension of landing zone to zones 0–2 by Ishimaru did
not completely prevent type IA endoleakage, with a
tendency to increased type IA endoleak rate (9.4 vs.
4.2 %, p=0.41) in this group.
Chimney technique as well as scallop or multilayered
prosthesis is an alternative for TEVAR with LSA coverage.
These procedures require long-lasting technical preparation so
they cannot be used in emergency cases. Another alternative
may be the use of multilayered stents—however, nowadays, it
delivers a lot of questions and has as many followers as
opponents. The effectiveness of these method requires further
investigation and trials; it cannot be recommended as a routine
approach to this particular pathology [17].
Due to the extensive circulation provided by the LSA,
coverage of the LSA can theoretically lead to grave compli-
cations, such as spinal cord ischaemia or cerebrovascular
incidents, or to usually better tolerated chronic left arm ischae-
mia or subclavian steal syndrome. Although infrequent, acute
upper extremity ischaemia has also been reported in the set-
ting of LSA coverage [18]. However, such risks may be
justified, especially in emergency situations in order to pre-
vent mentioned endoleakage. In our population, there was a
significant predominance of acute cases in group where LSA
origin was covered (52.8 vs. 29.2 %, p=0.007).
The management of intentional LSA coverage, particularly
in elective setting, remains a matter of debate. Reports of a low
incidence of left arm ischaemia shifted the pendulum towards
the liberal coverage of the LSA as an attractive means of
extending proximal landing zone in the early years of
TEVAR [19, 20]. This complication, if it occurs, is well-
tolerated in the vast majority of cases; if necessary,
revascularisation may be implemented in an elective setting
Table 6 Detailed 30-day
mortality
TAA thoracic aortic aneurysm,
MOF multiorgan failure, MI
myocardial infarction, TAT tho-
racic aorta transection, PE pul-
monary embolism
Patient Post-op day Indications Cause of death
Group A (n=6, 11.3 %)
1 24 TAA MOF after MI with circulatory
arrest on post-op day 4
2 Intraoperative Ruptured TAA Hypovolemic shock
3 23 TAT MOF
4 21 Complicated type B dissection MOF
5 0 Ruptured TAA Hypovolemic shock, MOF
6 17 TAT, multitrauma PE
Group B (n=8, 11.1 %)
1 10 Complicated type B dissection Retrograde type A dissection
2 4 TAA MI
3 1 TAA Access site injury
4 1 Ruptured TAA Hypovolemic shock
5 3 Complicated type B dissection MOF
6 1 TAA Intraprocedural SMA origin
occlusion, S-G extraction, MOF
7 10 TAA MOF
8 6 Symptomatic TAA MI





Mortality 6 (11.3 %) 8 (11.1 %)
MI 0 2 (2.8 %)
Reverse type A dissection 0 1 (1.4 %)




0 1 (1.4 %)
MOF 4 (7.5 %) 2 (2.8 %)
Hypovolemic shock 1 (1.9 %) 1 (1.4 %)
PE 1 (1.9 %) 0
Morbidity 4 (7.5 %) 10 (13.9 %)
Stroke 1 (1.9 %) 1 (1.4 %)
Paraplegia 0 1 (1.4 %)
SSS 1 (1.9 %) 0
Left arm ischemia 1 (1.9 %) 0
MI 1 (1.9 %) 3 (4.2 %)
Access site complications 0 5 (6.8 %)
MI myocardial infarction, SMA superior mesenteric artery, MOF
multiorgan failure, PE pulmonary embolism, SSS subclavian steal
syndrome
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[21]. Still, reports of devastating neurological complications
and studies showing an increased incidence of CVA and SCI
have been published [22–25], calling for a reconsideration of
the liberal LSA coverage policy.
However, the problem of additional risks associated with an
extra procedure (LSA revascularisation) remains, and its neces-
sity has been disputed [5, 26–28]. In fact, a high rate of com-
plications, such as stroke (6.6 %) [26] and phrenic nerve injury
(12.6 %) [24], has been reported. The most recent analysis
published by Madenci et al. revealed a combined CVA and
death rate of 5.3 % for isolated LSA reconstructions [29].
There was an attempt to standardise such care, and the
Society for Vascular Surgery (SVS) [10] proposed recommen-
dations based on selected trials and meta-analyses. Internally,
the SVS recommendation graded the level of evidence as
low—2C [10]. In a literature review from 2011, the
European Association for Cardio-thoracic Surgery [11]
strongly recommends prophylactic LSA revascularisation in
elective patients. Still, level I evidence is non-existent.
The aim of this study was to examine the real-life results
(tertiary centre providing aortic care to a population of ~2.3
million) of a selective LSA revascularisation strategy based on
absolute indications only.
CVA
In our group of patients with LSA coverage, one stroke occurred
in a patient with an unintentional occlusion of left common
carotid artery origin. It appears that this stroke (ischaemic focus
in left frontal lobe) was directly related to left common carotid
artery occlusion and not to LSA coverage.
However, a significant number of case series and meta-
analyses have revealed an increased incidence of CVA in patients
with LSA coverage without revascularisation [23, 30–32] and
stroke protection by pre-TEVAR restoration of LSA flow [22,
33]. The reason for this is not clear, as many series did not report
whether the strokes were in the posterior or anterior circulation.
Posterior circulation strokes may indeed result from hypoperfu-
sion caused by LSA coverage. However, anterior circulation
strokes are instead often the result of embolisation caused by
increased instrumentation in the aortic arch, which often is the
case in zone 2 TEVAR procedures. Therefore, LSA coverage
may be just an indirect marker of more advanced aortic disease
with a higher hazard of embolisation. In fact, several recent
papers explaining the reported stroke territory were found to
support this theory [34–36]. The embolisation theory may also
explain why numerous authors found LSA revascularisation to
be ineffective in reducing the stroke rate [7, 12, 13, 23, 35, 37].
Furthermore, recent analysis by Maldonado et al. revealed that
LSA revascularisation may even be harmful to certain patients
(fourfold higher stroke incidence in females with LSA
revascularisation) [14].
In our studied group, there were no other complications
than the aforementioned stroke, meaning that neither emboli-
sation strokes from the anterior circulation nor hypoperfusion
strokes from the posterior circulation occurred.
Only 34 % (n=18) of our patients were aged older than
70 years, making a relatively young population with a median
age of 61. Secondly, only 43.4% (n=23) of patients had thoracic
Fig. 1 Kaplan-Meier survival
outcomes for patients with and
without coverage of LSA
with TEVAR
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aortic aneurysm. Those two facts may indirectly indicate that our
population had a low grade of either arch atheroma or thrombus
and may explain the low incidence of CVA (an increased chance
of CVA due to significant arch atheroma in patients >70 years of
age was previously postulated [36, 38]).
SCI
Our population of patients with LSA coverage without prior
revascularisation had no SCI after a 30-day observation. This
finding is in accordance with those of other studies in which
selective LSA revascularisation was performed [7, 12, 13].
Apart from the debate on the influence of LSA coverage on
the incidence of SCI, these are the well-known risk factors for
paraplegia: coverage of a long segment of the aorta, use ofmore
than three elements of stent grafts during the procedure, prior
open abdominal aortic surgery and renal insufficiency [22].
Coverage of the aortic segment longer than 200 mm was
found to be an independent risk factor for SCI by Kotelis [7].
The median length of the covered aorta in group A was
205 mm; however, the number of patients with a coverage
of >200 mm may be more important. In our population, only
33.9 % (n=18) of patients had segments longer than 200 mm
covered, which may partially explain our good results.
Additionally, none of our patients had more than two elements
implanted; only the implantation of more than three elements
significantly increases the risk of paraplegia, according to the
EUROSTAR investigators [22].
We did not observe the influence of prior abdominal aortic
repair on an increased early rate of SCI in the covered-LSA non-
revascularised group. We had five patients with prior AAA
surgery in the covered-LSA group, and none of them had SCI.
However, all of these cases were elective. Czerny recently
postulated that the coverage of two vascular territories in situa-
tions of hemodynamic instabilitymay increase the chance of SCI
[39]. The elective setting and no hemodynamic instability of
these five cases may explain why no SCI occurred. Furthermore,
hypogastric artery status would provide valuable additional in-
sight into these cases; however, we have no such information in
our case notes, hampering any conclusions.
Another factor playing a role in the explanation for the low
SCI rate is that none of our patients of group A had renal
insufficiency, which is known to be an independent risk factor
[7, 22].
In the follow-up period, we recorded one case of paraplegia,
which occurred in the seventh post-operative month. The para-
plegia was due to spinal ischaemia with an ischemic focus at the
level of T6–T8 and occurred in a patient who had an increased
risk of early SCI based on the presence of one known risk factor
(prior AAA open repair). In the follow-up CT, just before the
occurrence of the paraplegia, a fresh type IA endoleakwas found.
We assume that, in this case, distal migration might have oc-
curred (endoleak IA); the Adamkiewicz artery might have been
occluded, resulting in paraplegia. The patient is ambulatory with
crutches and is on a waiting list for proximal TEVAR extension.
Our results show that the implementation of a strategy of
selective LSA revascularisation within a real-world, consecutive
TEVAR population resulted in a low incidence of neurological
complications. Lownumber of incidents did not allow to conduct
a multivariate statistical analyses regarding SCI and CVA, which
is a clear limitation of this study. Even if a relatively small sample
size and heterogeneous pathology group may have biased our
data, our per-procedure conclusions still stand.
However, we do foresee the necessity of further multicentre
studies that report the combined morbidity of TEVAR with
prophylactic LSA revascularisation vs. the morbidity of
TEVAR without LSA revascularisation (preferably with all
of the patients’ data included on an intention-to-treat basis) as
the next step in solving the on-going debate.
Conclusion
Our analysis, although retrospective and based on one institution
experience, shows a realistic population of TEVAR patients. We
prove that TEVAR with coverage of LSA origin can be accom-
plished with minimal neurological morbidity in this patient pop-
ulation. The study shows that LSA revascularisation is not
mandatory before endograft deployment, especially in emergen-
cy settings. We also prove that although zone 2 TEVAR extends
to the proximal landing zone, it does not prevent type IA
endoleaks from appearing. A multicentre randomised control
trial with higher number of patients is necessary for proper,
robust conclusion to be established.
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